首页> 外文期刊>JMIR Research Protocols >Engagement Strategies for Self-Monitoring Symptoms of Bipolar Disorder With Mobile and Wearable Technology: Protocol for a Randomized Controlled Trial
【24h】

Engagement Strategies for Self-Monitoring Symptoms of Bipolar Disorder With Mobile and Wearable Technology: Protocol for a Randomized Controlled Trial

机译:移动和可穿戴技术的双相情感障碍自我监测症状的参与策略:随机对照试验协议

获取原文
           

摘要

Background Monitoring signs and symptoms in bipolar disorder (BP) is typically based on regular assessments from patient-clinician interactions. Mobile and wearable technology promises to make monitoring symptoms in BP easier, but little is known about how best to engage individuals with BP in monitoring symptoms. Objective The objective of this study was to provide the rationale and protocol for a randomized controlled trial that investigates engagement strategies for monitoring symptoms of BP, including the strategies of using activity trackers compared with self-reports and reviewing recorded symptoms weekly with an interviewer. Methods A total of 50 individuals with BP will be recruited from the Prechter Longitudinal Study of Bipolar Disorder at the University of Michigan to participate in a 6-week study. Participants will monitor their symptoms through an activity tracker (Fitbit Alta HR) and a mobile phone app designed for this study. In addition to monitoring symptoms, participants have a 50-50 chance of being assigned to an arm that reviews self-reports and activity information weekly. Statistical tests will be performed to test hypotheses that participants adhere to activity tracking significantly more than self-reporting, prefer activity tracking significantly more than self-reporting, and better adhere to both activity tracking and self-reporting when reviewing collected information weekly. Results Recruitment commenced in November 2017. The first group of participants began the study in January 2018. Conclusions This study aims to establish strategies to engage individuals with BP in monitoring their symptoms with mobile and wearable technology. Better engagement strategies are expected to aid current efforts in bipolar research and clinical care, from the development of new mobile phone apps to providing the right intervention to the right individual at the right moment. Trial Registration ClinicalTrials.gov {"type":"clinical-trial","attrs":{"text":"NCT03358238","term_id":"NCT03358238"}} NCT03358238 ; https://clinicaltrials.gov/ct2/show/ {"type":"clinical-trial","attrs":{"text":"NCT03358238","term_id":"NCT03358238"}} NCT03358238 (Archived by WebCite at http://www.webcitation.org/6yebuNfz5) Registered Report Identifier RR1-10.2196/9899.
机译:背景技术监测双相情感障碍(BP)的体征和症状通常基于患者与临床医生之间的互动进行的定期评估。移动和可穿戴技术有望使对BP的症状的监测更加容易,但是对于如何最好地使BP个体参与监测症状知之甚少。目的这项研究的目的是为一项随机对照试验提供理论依据和方案,该试验研究用于监测BP症状的参与策略,包括使用活动追踪器与自我报告进行比较的策略以及每周与访调员一起检查记录的症状的策略。方法从密歇根大学的Prechter双相情感障碍纵向研究中招募50位BP个体,参加为期6周的研究。参与者将通过活动跟踪器(Fitbit Alta HR)和专为该研究设计的手机应用程序监视症状。除了监测症状外,参与者还有50-50的机会被分配到每周检查一次自我报告和活动信息的部门。将执行统计检验,以检验以下假设:参与者比自我报告要更多地遵循活动跟踪,比自我报告要更偏重活动跟踪,并且在每周查看收集的信息时更好地遵循活动跟踪和自我报告。结果招募于2017年11月开始。第一批参与者于2018年1月开始研究。结论本研究旨在建立使BP个体参与通过移动和可穿戴技术监测其症状的策略。从开发新的手机应用程序到在适当的时候为适当的个人提供适当的干预措施,预计更好的参与策略将有助于当前在双相研究和临床护理方面的工作。试验注册ClinicalTrials.gov {“ type”:“ clinical-trial”,“ attrs”:{“ text”:“ NCT03358238”,“ term_id”:“ NCT03358238”}} NCT03358238; https://clinicaltrials.gov/ct2/show/ {“ type”:“ clinical-trial”,“ attrs”:{“ text”:“ NCT03358238”,“ term_id”:“ NCT03358238”}} NCT03358238(由WebCite存档请访问http://www.webcitation.org/6yebuNfz5)注册报告标识符RR1-10.2196 / 9899。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号